SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

SLX Silex Systems Limited

Technology · Semiconductors · website
$4.17
52wk 4.07 – 10.85
Overall
44.3
Value
29.6
Growth
100.0
Health
69.2
Quality
0.6
Momentum
0.3
Dividend
—
Price
About Silex Systems Limited

Silex Systems Limited, a technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser enrichment technology in Australia, the United States, and the United Kingdom. It operates through three segments: Silex Systems, Translucent, and Silex USA. The company also sells its cREO technology. In addition, it develops its laser-based enrichment technology for use in various applications comprising uranium production and enrichment for nuclear power; silicon enrichment for silicon quantum computing; and medical isotope enrichment for new cancer therapies. Silex Systems Limited was incorporated in 1987 and is based in Lucas Heights, Australia.

Price analytics

Returns

1 day -0.5%
1 week -5.2%
1 month -15.8%
3 months -18.6%
6 months -29.0%
1 year -39.7%
3 years 33.2%

Risk

Volatility (1y ann.) 81.0%
Beta vs ASX 200 3.03
Sharpe (1y) -0.25
VaR 95% (1-day) -7.9%
Max drawdown (1y) -60.2%
Off 1-year high -60.2%

Technicals

RSI(14) 37
vs 50DMA -14.3%
vs 200DMA -28.3%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 29.6
Trailing P/E
—
Forward P/E
100
PEG ratio
0
EV / EBITDA
0
Price / Book
31
Price / Sales
0
Growth 100.0
Revenue growth (1y)
100
Revenue CAGR (3y)
100
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 69.2
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow) 0.6
Return on equity
0
Return on assets
3
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 0.3
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
0
Position in 52-week range
2

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$1.16B
P/E (trailing)
—
P/E (forward)
-82.61
EPS (trailing)
-0.14
Dividend yield
—
Payout ratio
0.0%
Beta
0.48
EV / EBITDA
1,140.40
Price / Book
5.77
ROE
-26.4%
Operating margin
-42.9%
Net margin
-204.7%
Total cash
$180.74M
Total debt
$642,197
Current ratio
29.46
Debt / Equity
0.00
Free cash flow
$1.67M
Avg volume
1.14M
Latest annual results (FY ending 30 Jun 2026)
  • Revenue$13.28M
  • Gross profit$13.28M
  • Operating income-$4.92M
  • Net income-$38.62M
  • Diluted EPS-0.14
  • Free cash flow$8.08M
  • Net debt-$15.39M
Sector peers (Technology)
TickerMkt cap P/EScore
XYZ $64.06B 131.6 53.7
CDA $12.30B 70.3 77.2
WTC $11.24B 43.4 39.9
XRO $10.22B — 39.3
TNE $9.99B 71.0 64.6
NXT $8.17B 89.5 38.0
MP1 $5.43B — 59.3
360 $4.99B 24.6 62.8